Case reportResolution of epithelial ingrowth after combined photorefractive keratectomy and corneal crosslinking in a patient with post-LASIK ectasiaKymionis, George D. MD, PhD1; Grentzelos, Michael A. MD, PhD1,*; Voulgari, Nafsika MD1; Hashemi, Kate MD1; Mikropoulos, Dimitrios MD, PhD2Author Information 1Department of Ophthalmology, University of Lausanne, Jules-Gonin Eye Hospital, Fondation Asile des aveugles, Lausanne, Switzerland 2University Department of Ophthalmology, AHEPA Hospital, Thessaloniki, Greece *Corresponding author: Michael A. Grentzelos MD, PhD, Department of Ophthalmology, University of Lausanne, Jules-Gonin Eye Hospital, Fondation Asile des aveugles, Lausanne, Switzerland. E-mail: email@example.com Submitted February 26, 2019; revised March 11, 2019; accepted March 12, 2019. Dr. Grentzelos was granted a scholarship from the Hellenic Society of Intraocular Implant and Refractive Surgery.Figure: No Caption available.First author: George D. Kymionis, MD, PhD Journal of Cataract & Refractive Surgery: July 2019 - Volume 45 - Issue 7 - p 1040-1042 doi: 10.1016/j.jcrs.2019.03.011 Buy Metrics Abstract A 34-year-old man was referred to our institute for evaluation of the left eye because of corneal ectasia 10 years after bilateral laser in situ keratomileusis (LASIK). Three months before his referral, the patient had a flap lift for the management of interface fluid accumulation. Topography demonstrated post-LASIK corneal ectasia and slitlamp evaluation revealed epithelial ingrowth in the stromal interface inferiorly. The patient underwent uneventful combined photorefractive keratectomy (PRK) and corneal crosslinking (CXL) to stabilize the corneal ectasia and improve his functional vision. One month after the treatment, slitlamp evaluation revealed complete resolution of stromal interface epithelial ingrowth. At 12 months postoperatively, significant visual and topographic improvement was noted without any evidence of epithelial ingrowth recurrence or corneal ectasia progression. Combined PRK-CXL seemed to not only treat the corneal pathology of this patient successfully, resulting in visual and topographic improvement, but it also resolved the stromal interface epithelial ingrowth. © 2019 by Lippincott Williams & Wilkins, Inc.